-
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
-
Candel Therapeutics to Participate in Upcoming Investor Conferences in September
-
Citi Starts Candel Therapeutics Inc. (CADL) at Buy, PT $25
-
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Candel Therapeutics (CADL) Prices Public Offering
-
Candel Therapeutics Announces Pricing of Public Offering
-
Candel Therapeutics (CADL) Announces $80 Million Proposed Public Offering
-
Candel Therapeutics Announces $80 Million Proposed Public Offering
-
Candel Therapeutics Upcoming Investor Conference Participation
-
Candel Therapeutics Upcoming Investor Conference Participation

